Evofem Biosciences Competitors and Similar CompaniesClear all

Evofem Biosciences's competitors and similar companies include Anika Therapeutics, Hallura and Trauer.

	Evofem Biosciences Evofem Biosciences, a clinical-stage biopharmaceutical company, develops and commercializes women’s sexual and reproductive health products.	Anika Therapeutics Anika Therapeutics develops, manufactures and commercializes therapeutic products for tissue protection, healing, and repair.	Hallura Hallura is an aesthetic medical company developing a new generation of hyaluronic acid (HA) dermal fillers.	Trauer Guangzhou Trauer Biotechnology (广州创尔生物技术股份有限公司) is a biomedical research and development company.
Founding Date	Founding Date 2007	Founding Date 1992	Founding Date 2017	Founding Date 2002
Type	Type Public	Type Public	Type Private	Type Public
Tags	Tags Healthcare biotech drug development health & beauty	Tags Healthcare biotech drug development health & beauty	Tags Healthcare biotech drug development health & beauty	Tags Healthcare biotech drug development health & beauty pharma
Locations	Locations San Diego, US HQ	Locations Bedford, US HQ Padova, IT Padova, IT Franklin, US	Locations Yokne'am Illit, IL HQ	Locations Guangzhou, CN HQ
Employees	Employees 3030% increase	Employees 15416% increase	Employees 215% increase	Employees 3289% decrease
Valuation ($)	Valuation ($) 1.2 m	Valuation ($) 365 m	Valuation ($) N/A	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) $20.2m (FY, 2025)	Revenue (est.) $112.8m (FY, 2025)	Revenue (est.) N/A	Revenue (est.) ¥390.8m (FY, 2025)
Cost of goods	Cost of goods $4.6m (FY, 2025)	Cost of goods $49m (FY, 2025)	Cost of goods N/A	Cost of goods ¥99.3m (FY, 2025)
Gross profit	Gross profit $15.6m (FY, 2025)	Gross profit $63.8m (FY, 2025)	Gross profit N/A	Gross profit ¥292.5m (FY, 2025)
Net income	Net income $391k (FY, 2025)	Net income ($10.9m) (FY, 2025)	Net income N/A	Net income ¥29m (FY, 2025)